cp wire

CP Wire Articles

Pfizer’s Xeljanz (tofacitinib), used to treat conditions such as rheumatoid arthritis and ulcerative colitis, has... read more
Wed, 02/20/19 - 11:50 am

On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of  common stock. The expected price is between $20 and $22 per share. The shares will be... read more

Tue, 02/19/19 - 09:53 am

CStone Pharmaceuticals is seeking to raise $282 Million in its upcoming Hong Kong IPO. The company's investors include Boyu Capital, Sequoia Capital, Oriza Holdings, and GIC.

The company... read more

Mon, 02/18/19 - 09:48 am

5AM Venture Management, LLC (5AM) of San Francisco, CA and Boston, MA announced on 2/13/19 the closing of two new venture capital funds, totaling $497 million in committed capital. The capital was... read more

Thu, 02/14/19 - 09:53 am

Cirius Therapeutics has updated it filing for a planned $86 million IPO. The date of the IPO still hasn't been set.

Cirius' lead candidate, MSDC-0602K, is a once daily, oral treatment for... read more

Thu, 02/14/19 - 09:38 am

Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announced on 2/13/19 that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an... read more

Wed, 02/13/19 - 05:02 pm

Beginning on March 1, China will reduce the VAT on a group of 21 rare disease drugs from 16% to 3%. The government's announcement did not specify which drugs would be in the group. The move may... read more

Wed, 02/13/19 - 09:38 am

Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced on 2/12/19 that ImmuneOncia, a joint venture formed in September 2016, has completed a private equity... read more

Tue, 02/12/19 - 09:55 am

Xeris Pharmaceuticals announced on 2/11/19 that it filed a registration statement with the Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of 5,000,000 shares... read more

Tue, 02/12/19 - 09:41 am

Seattle Genetics (Nasdaq:SGEN) announced on 2/11/19 that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing... read more

Mon, 02/11/19 - 10:11 am

Shockwave Medical filed for its IPO on 2/8/19. While the filing did not list the number of shares to be offered or the expected offering price, the offering will bring in an expected maximum of $... read more

Mon, 02/11/19 - 09:53 am

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced on 2/8/19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation... read more

Fri, 02/8/19 - 09:37 am

HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched today with $60.75M in Series A funding led by ARCH Venture Partners.... read more

Thu, 02/7/19 - 09:53 am

Vaxart has filed for an upcoming stock offering with the number of shares yet to be announced. Vaxart is developing oral vaccines based on it proprietary oral recombinant vaccine technology. The... read more

Thu, 02/7/19 - 09:37 am

Sunstone Life Science Ventures today announced the first closing of its Sunstone Life Science Ventures Fund IV ("Sunstone LSV IV") at $91 million. The investment strategy of the new fund is a... read more

Wed, 02/6/19 - 12:07 pm

Indivior PLC (LON: INDV) (“Indivior” or the “Company”) announced on 2/2/19 that it has entered into a definitive agreement to divest its rights related to the Sai Bo Song (buprenorphine, naloxone... read more

Wed, 02/6/19 - 09:30 am

Harpoon Therapeutics announced that it will raise up to $93 million in its IPO. The company is offering 5,400,000 shares and is granting underwriters the option to purchase up to an additional 810... read more

Mon, 02/4/19 - 09:16 pm

Avedro, Inc. (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or... read more

Mon, 02/4/19 - 10:14 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.